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Soluble epoxide hydrolase (sEH) is an enzyme with multiple functions that has two 
distinct enzyme activities: epoxide hydrolase (C-terminal domain) and phosphatase 
(N-terminal domain). The endogenous substrates of epoxide hydrolase are 
epoxyeicosatrienoic acids (EETs) that are hydrolyzed by sEH to corresponding diols, 
dihydroxyeicosatrienoic acids (DHETs). The N-terminal domain metabolizes 
lysophosphatidic acids (LPAs). In this study, I investigated the catalytic activity of sEH 
isolated from Xenopus laevis and the metabolism of lysophosphatidic acids (LPAs) by 
allelic variants of human sEH. Firstly the catalytic activities of both N/C terminal 
domains of sEH were investigated. Xenopus sEH cDNA was isolated from embryos of 
Xenopus laevis. The Xenopus sEH was expressed in Escherichia coli and was purified. 
The purified Xenopus sEH did not show phosphatase activity toward 
4-methylumbelliferyl phosphate (4-MUP) or several LPAs although it had EH activity. 
The epoxide hydrolase activity of sEH seemed to be similar to that of human sEH, while 
Xenopus sEH did not have phosphatase activity toward several substrates that human 
sEH metabolizes. In contrast, to elucidate the sEH phosphatase activity that metabolizes 
LPAs, the human sEH were used. A purified wild-type (WT) and six allelic variants of 
sEH (K55R, R103C, C154Y, R287Q, V422A, and E470G) were used in this study. The 
R103C and R287Q variants revealed significant lower activity than WT sEH. The kinetic 
study indicated that R103C and R287Q variants had lower Vmax/Km ratio toward 
stearoyl-LPA than other variants. Regarding the effect of sEH allelic variants on VEGF 
expression, all variants except V442A revealed suppressed VEGF mRNA levels in Hep3B 
cells. These results suggest that the R103C and R287Q variants have lower phosphatase 
activity, however, all allelic variants except V442A have similar effect to the VEGF 
suppression.  
 
